ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA-LNP (Lipid Nanoparticle) Formulation Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-0G18899
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024
BUY CHAPTERS

Global RNA-LNP (Lipid Nanoparticle) Formulation Market Research Report 2024

Code: QYRE-Auto-0G18899
Report
November 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LNP
WuXi XDC
GenScript
Creative Biogene
Creative-Biolabs
Precigenome
Catalent
Curapath
Recipharm
RiboPro
VectorBuilder
CordenPharma
Thermo Fisher Scientific
ProMab

RNA-LNP (Lipid Nanoparticle) Formulation Market

The global RNA-LNP (Lipid Nanoparticle) Formulation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
RNA-LNP formulation refers to the encapsulation of RNA molecules in lipid nanoparticles (LNP) to achieve effective drug delivery and gene therapy. As a carrier, LNP can protect RNA molecules from degradation while promoting their delivery and cellular uptake in the body.
North American market for RNA-LNP (Lipid Nanoparticle) Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA-LNP (Lipid Nanoparticle) Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA-LNP (Lipid Nanoparticle) Formulation in Drug Delivery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA-LNP (Lipid Nanoparticle) Formulation include WuXi XDC, GenScript, Creative Biogene, Creative Biolabs, Precigenome LLC, Catalent, Curapath, Recipharm AB, RiboPro, VectorBuilder Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA-LNP (Lipid Nanoparticle) Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-LNP (Lipid Nanoparticle) Formulation.
The RNA-LNP (Lipid Nanoparticle) Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA-LNP (Lipid Nanoparticle) Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA-LNP (Lipid Nanoparticle) Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of RNA-LNP (Lipid Nanoparticle) Formulation Market Report

Report Metric Details
Report Name RNA-LNP (Lipid Nanoparticle) Formulation Market
Segment by Type
  • Circular RNA-LNP Formulation
  • mRNA-LNP Formulation
  • Other
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WuXi XDC, GenScript, Creative Biogene, Creative Biolabs, Precigenome LLC, Catalent, Curapath, Recipharm AB, RiboPro, VectorBuilder Inc., CordenPharma, Thermo Fisher Scientific, ProMab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of RNA-LNP (Lipid Nanoparticle) Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA-LNP (Lipid Nanoparticle) Formulation Market report?

Ans: The main players in the RNA-LNP (Lipid Nanoparticle) Formulation Market are WuXi XDC, GenScript, Creative Biogene, Creative Biolabs, Precigenome LLC, Catalent, Curapath, Recipharm AB, RiboPro, VectorBuilder Inc., CordenPharma, Thermo Fisher Scientific, ProMab

What are the Application segmentation covered in the RNA-LNP (Lipid Nanoparticle) Formulation Market report?

Ans: The Applications covered in the RNA-LNP (Lipid Nanoparticle) Formulation Market report are Drug Delivery, Vaccine Development, Other

What are the Type segmentation covered in the RNA-LNP (Lipid Nanoparticle) Formulation Market report?

Ans: The Types covered in the RNA-LNP (Lipid Nanoparticle) Formulation Market report are Circular RNA-LNP Formulation, mRNA-LNP Formulation, Other

Recommended Reports

RNA Therapeutics

mRNA & Vaccines

Lipid Nanoparticles

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Circular RNA-LNP Formulation
1.2.3 mRNA-LNP Formulation
1.2.4 Other
1.3 Market by Application
1.3.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Delivery
1.3.3 Vaccine Development
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Perspective (2019-2030)
2.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Growth Trends by Region
2.2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Region (2019-2024)
2.2.3 RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Region (2025-2030)
2.3 RNA-LNP (Lipid Nanoparticle) Formulation Market Dynamics
2.3.1 RNA-LNP (Lipid Nanoparticle) Formulation Industry Trends
2.3.2 RNA-LNP (Lipid Nanoparticle) Formulation Market Drivers
2.3.3 RNA-LNP (Lipid Nanoparticle) Formulation Market Challenges
2.3.4 RNA-LNP (Lipid Nanoparticle) Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Revenue
3.1.1 Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Revenue (2019-2024)
3.1.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Players (2019-2024)
3.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA-LNP (Lipid Nanoparticle) Formulation Revenue
3.4 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Concentration Ratio
3.4.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-LNP (Lipid Nanoparticle) Formulation Revenue in 2023
3.5 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation Head office and Area Served
3.6 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Product and Application
3.7 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-LNP (Lipid Nanoparticle) Formulation Breakdown Data by Type
4.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Type (2019-2024)
4.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Type (2025-2030)
5 RNA-LNP (Lipid Nanoparticle) Formulation Breakdown Data by Application
5.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Application (2019-2024)
5.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
6.2 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
6.4 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
7.2 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
7.4 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
8.2 Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
9.2 Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
9.4 Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
10.2 Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi XDC
11.1.1 WuXi XDC Company Details
11.1.2 WuXi XDC Business Overview
11.1.3 WuXi XDC RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.1.4 WuXi XDC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.1.5 WuXi XDC Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.2.4 GenScript Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Creative Biogene
11.3.1 Creative Biogene Company Details
11.3.2 Creative Biogene Business Overview
11.3.3 Creative Biogene RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.3.4 Creative Biogene Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.3.5 Creative Biogene Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.4.4 Creative Biolabs Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.4.5 Creative Biolabs Recent Development
11.5 Precigenome LLC
11.5.1 Precigenome LLC Company Details
11.5.2 Precigenome LLC Business Overview
11.5.3 Precigenome LLC RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.5.4 Precigenome LLC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.5.5 Precigenome LLC Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.6.4 Catalent Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.6.5 Catalent Recent Development
11.7 Curapath
11.7.1 Curapath Company Details
11.7.2 Curapath Business Overview
11.7.3 Curapath RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.7.4 Curapath Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.7.5 Curapath Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Details
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.8.4 Recipharm AB Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.8.5 Recipharm AB Recent Development
11.9 RiboPro
11.9.1 RiboPro Company Details
11.9.2 RiboPro Business Overview
11.9.3 RiboPro RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.9.4 RiboPro Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.9.5 RiboPro Recent Development
11.10 VectorBuilder Inc.
11.10.1 VectorBuilder Inc. Company Details
11.10.2 VectorBuilder Inc. Business Overview
11.10.3 VectorBuilder Inc. RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.10.4 VectorBuilder Inc. Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.10.5 VectorBuilder Inc. Recent Development
11.11 CordenPharma
11.11.1 CordenPharma Company Details
11.11.2 CordenPharma Business Overview
11.11.3 CordenPharma RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.11.4 CordenPharma Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.11.5 CordenPharma Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.12.4 Thermo Fisher Scientific Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 ProMab
11.13.1 ProMab Company Details
11.13.2 ProMab Business Overview
11.13.3 ProMab RNA-LNP (Lipid Nanoparticle) Formulation Introduction
11.13.4 ProMab Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
11.13.5 ProMab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
LNP
WuXi XDC
GenScript
Creative Biogene
Creative-Biolabs
Precigenome
Catalent
Curapath
Recipharm
RiboPro
VectorBuilder
CordenPharma
Thermo Fisher Scientific
ProMab
List of Tables
 Table 1. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Circular RNA-LNP Formulation
 Table 3. Key Players of mRNA-LNP Formulation
 Table 4. Key Players of Other
 Table 5. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2019-2024)
 Table 9. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2025-2030)
 Table 11. RNA-LNP (Lipid Nanoparticle) Formulation Market Trends
 Table 12. RNA-LNP (Lipid Nanoparticle) Formulation Market Drivers
 Table 13. RNA-LNP (Lipid Nanoparticle) Formulation Market Challenges
 Table 14. RNA-LNP (Lipid Nanoparticle) Formulation Market Restraints
 Table 15. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Players (2019-2024)
 Table 17. Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-LNP (Lipid Nanoparticle) Formulation as of 2023)
 Table 18. Ranking of Global Top RNA-LNP (Lipid Nanoparticle) Formulation Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by RNA-LNP (Lipid Nanoparticle) Formulation Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Headquarters and Area Served
 Table 21. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Product and Application
 Table 22. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Type (2019-2024)
 Table 26. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Type (2025-2030)
 Table 28. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Application (2019-2024)
 Table 30. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Application (2025-2030)
 Table 32. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)
 Table 47. WuXi XDC Company Details
 Table 48. WuXi XDC Business Overview
 Table 49. WuXi XDC RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 50. WuXi XDC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 51. WuXi XDC Recent Development
 Table 52. GenScript Company Details
 Table 53. GenScript Business Overview
 Table 54. GenScript RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 55. GenScript Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 56. GenScript Recent Development
 Table 57. Creative Biogene Company Details
 Table 58. Creative Biogene Business Overview
 Table 59. Creative Biogene RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 60. Creative Biogene Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 61. Creative Biogene Recent Development
 Table 62. Creative Biolabs Company Details
 Table 63. Creative Biolabs Business Overview
 Table 64. Creative Biolabs RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 65. Creative Biolabs Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 66. Creative Biolabs Recent Development
 Table 67. Precigenome LLC Company Details
 Table 68. Precigenome LLC Business Overview
 Table 69. Precigenome LLC RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 70. Precigenome LLC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 71. Precigenome LLC Recent Development
 Table 72. Catalent Company Details
 Table 73. Catalent Business Overview
 Table 74. Catalent RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 75. Catalent Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 76. Catalent Recent Development
 Table 77. Curapath Company Details
 Table 78. Curapath Business Overview
 Table 79. Curapath RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 80. Curapath Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 81. Curapath Recent Development
 Table 82. Recipharm AB Company Details
 Table 83. Recipharm AB Business Overview
 Table 84. Recipharm AB RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 85. Recipharm AB Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 86. Recipharm AB Recent Development
 Table 87. RiboPro Company Details
 Table 88. RiboPro Business Overview
 Table 89. RiboPro RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 90. RiboPro Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 91. RiboPro Recent Development
 Table 92. VectorBuilder Inc. Company Details
 Table 93. VectorBuilder Inc. Business Overview
 Table 94. VectorBuilder Inc. RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 95. VectorBuilder Inc. Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 96. VectorBuilder Inc. Recent Development
 Table 97. CordenPharma Company Details
 Table 98. CordenPharma Business Overview
 Table 99. CordenPharma RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 100. CordenPharma Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 101. CordenPharma Recent Development
 Table 102. Thermo Fisher Scientific Company Details
 Table 103. Thermo Fisher Scientific Business Overview
 Table 104. Thermo Fisher Scientific RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 105. Thermo Fisher Scientific Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 106. Thermo Fisher Scientific Recent Development
 Table 107. ProMab Company Details
 Table 108. ProMab Business Overview
 Table 109. ProMab RNA-LNP (Lipid Nanoparticle) Formulation Product
 Table 110. ProMab Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)
 Table 111. ProMab Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. RNA-LNP (Lipid Nanoparticle) Formulation Picture
 Figure 2. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type: 2023 VS 2030
 Figure 4. Circular RNA-LNP Formulation Features
 Figure 5. mRNA-LNP Formulation Features
 Figure 6. Other Features
 Figure 7. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application: 2023 VS 2030
 Figure 9. Drug Delivery Case Studies
 Figure 10. Vaccine Development Case Studies
 Figure 11. Other Case Studies
 Figure 12. RNA-LNP (Lipid Nanoparticle) Formulation Report Years Considered
 Figure 13. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region: 2023 VS 2030
 Figure 16. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Players in 2023
 Figure 17. Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-LNP (Lipid Nanoparticle) Formulation as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by RNA-LNP (Lipid Nanoparticle) Formulation Revenue in 2023
 Figure 19. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)
 Figure 21. United States RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)
 Figure 25. Germany RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2019-2030)
 Figure 33. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)
 Figure 41. Mexico RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)
 Figure 45. Turkey RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. WuXi XDC Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 49. GenScript Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 50. Creative Biogene Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 51. Creative Biolabs Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 52. Precigenome LLC Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 53. Catalent Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 54. Curapath Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 55. Recipharm AB Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 56. RiboPro Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 57. VectorBuilder Inc. Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 58. CordenPharma Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 59. Thermo Fisher Scientific Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 60. ProMab Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024
Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025
Global circRNA LNP Formulation Market Research Report 2024
Global Lipid Nanoparticle LNP Development Service Market Research Report 2025
Global LNP Synthesis System Market Research Report 2024
Global Lipid Nanoparticles LNP Market Research Report 2024
Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024
Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025
Global Lipid Nanoparticle LNP Services Market Research Report 2025
Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024
Global Lipid Nanoparticles LNPs CDMO Service Market Research Report 2024
Global mRNA Delivery System Market Research Report 2024
Global Carrier RNA Market Research Report 2025
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024
Global Lipid Nanoparticle Development Service Market Research Report 2024
Global Nanoparticle Drug Delivery Systems Market Research Report 2024
Global Nucleic Acid Nanotechnology Market Research Report 2024
Global Lipid Nanoparticle CDMO Market Research Report 2025
RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions